Option Care (OPCH) CEO receives 78,876-share restricted stock grant

Rhea-AI Filing Summary

Option Care Health, Inc. reported that Chief Executive Officer John Charles Rademacher acquired 78,876 shares of common stock through a grant of restricted stock units. The award was at a stated price of $0.00 per share and increases his directly held position to 831,057 shares. These restricted stock units vest in three equal annual installments on the first, second, and third anniversaries of the grant date.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider RADEMACHER JOHN CHARLES

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	78,876	$0.00	--

Holdings After Transaction: Common Stock — 831,057 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

RADEMACHER JOHN CHARLES

(Last) (First) (Middle)

C/O OPTION CARE HEALTH, INC.

3000 LAKESIDE DRIVE, SUITE 300N

(Street)

BANNOCKBURN IL 60015

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Option Care Health, Inc. [ OPCH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/18/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/18/2026		A		78,876(1)	A	$0	831,057	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The restricted stock units granted in this award vest as to one third of the underlying shares of common stock on each of the first, second, and third anniversary of the grant date.

	/s/ Michael Bavaro, attorney-in-fact for Mr. Rademacher	02/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Option Care Health (OPCH) report for its CEO?

Option Care Health reported that CEO John Charles Rademacher received a grant of 78,876 restricted stock units. These units represent common stock and were awarded at a stated price of $0.00 per share as part of his equity-based compensation.

How many Option Care Health (OPCH) shares does the CEO hold after this Form 4?

After the reported grant, CEO John Charles Rademacher directly owns 831,057 shares of Option Care Health common stock. This figure reflects his updated holdings following the acquisition of 78,876 restricted stock units reported in the Form 4 filing.

How do the new restricted stock units for OPCH’s CEO vest?

The restricted stock units granted to the Option Care Health CEO vest over three years. One third of the underlying common shares vests on each of the first, second, and third anniversaries of the grant date, subject to the award’s terms.

Was cash paid for the 78,876 OPCH shares reported in this Form 4?

No cash was paid for these 78,876 shares, as they were granted as restricted stock units at a stated price of $0.00 per share. The transaction represents an equity award rather than an open-market stock purchase.

Is the OPCH CEO’s new equity award a direct or indirect holding?

The equity reported in this Form 4 is held as a direct ownership position. The filing classifies the CEO’s holdings as direct, with no indicated intermediary entity or indirect ownership structure in the reported transaction.